23 November 2024NewsAmericasChristina MacDougall, Partner, Morgan Lewis | Susan Evans, Senior Director, Intellectual Property, IGM Biosciences | Lawrence Rozsnyai, Vice President of Intellectual Property, Lycia Therapeutics | Reena Bajpai, Senior Counsel II, Gilead Sciences

WATCH: Strategies for success - patent drafting and application

Panellists from IGM Biosciences, Lycia Therapeutics, Gilead Sciences, and Morgan Lewis delve into how thoughtful patent drafting can improve prosecution outcomes and strengthen overall IP strategy.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

‘It’s going to be very different’: INTA CEO shares London meeting plans

'Scrap the billable hour': LSIPR joins INTA panel on gender diversity

Sanofi unit loses genetic disorder patent at EPO after trio of challenges

INTA confirms London as host city for Annual Meeting 2026

INTA unveils key principles on AI and IP rights at Annual Meeting

Illumina takes aim at rival in gene sequencing spat

Novartis tops Big Pharma in global trademark portfolios

PierFerd hires partner with medtech expertise

WATCH: Strategies for success - patent drafting and application

Editor's picks

Editor's picks

More features